The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Innovace 20 mg Tablets



IMED Healthcare Ltd.PPA1463/208/002

Main Information

Trade NameInnovace 20 mg Tablets
Active SubstancesEnalapril maleate
Dosage FormTablet
Licence HolderIMED Healthcare Ltd.
Licence NumberPPA1463/208/002

Group Information

ATC CodeC09AA ACE inhibitors, plain
C09AA02 enalapril

Status

License statusAuthorised
Licence Issued07/07/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back